Literature DB >> 29447417

Primary Central Nervous System Lymphoma-PART 1: Epidemiology, Diagnosis, Staging, and Prognosis.

Rimas V Lukas, Roger Stupp, Vinai Gondi, Jeffrey J Raizer.   

Abstract

Primary central nervous system (CNS) lymphoma is a rare CNS neoplasm. Its highest incidence is in the elderly and the immunocompromised. The initial steps in establishing a diagnosis involve CNS imaging. Familiarity with the clinical presentation is important in order to limit the risk of a nondiagnostic biopsy. In addition to confirming the diagnosis, it is wise to evaluate for extra-CNS disease. There are important differences in the presentation and evaluation of immunocompetent patients and those of immunocompromised patients; we will delineate these in this review. Appropriate initial clinical evaluations facilitate optimal therapeutic management for patients with primary CNS lymphoma. This is of particular importance because primary CNS lymphoma is a potentially curable disease, despite the high likelihood of recurrence.

Entities:  

Mesh:

Year:  2018        PMID: 29447417

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  8 in total

Review 1.  Clinical neuro-oncology for the neurologist.

Authors:  Rimas V Lukas; Jennie W Taylor; Sylvia C Kurz; Nimish A Mohile
Journal:  Neurol Clin Pract       Date:  2020-10

2.  Primary central nervous system lymphoma and 5-aminolevulinic acid.

Authors:  Pierre Ferrer; Pablo Barbero; Gonzalo Monedero; Anna Lo Presti; Bartolome Bejarano; Juan Ramon Penanes
Journal:  Surg Neurol Int       Date:  2020-05-23

Review 3.  The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies - A Narrative Review.

Authors:  Paulina Stefaniuk; Agnieszka Szymczyk; Monika Podhorecka
Journal:  Cancer Manag Res       Date:  2020-04-29       Impact factor: 3.989

4.  An Unusual Case of Concurrent Herpes Simplex Virus Type 1 and Cytomegalovirus Encephalitis Complicated by Primary Central Nervous System Lymphoma as an Initial Presentation of Acquired Immunodeficiency Syndrome.

Authors:  Dawood Findakly
Journal:  Cureus       Date:  2021-11-15

5.  CNS Lymphoma: Clinical Pearls and Management Considerations.

Authors:  Michelot Michel; Noelle Lucke-Wold; Mohammad Reza Hosseini; Eric Panther; Ramya Reddy; Brandon Lucke-Wold
Journal:  Biomed Res Clin Rev       Date:  2022-06-27

Review 6.  Multimodal diagnostic imaging in primary vitreoretinal lymphoma.

Authors:  Lucy T Xu; Ye Huang; Albert Liao; Casey L Anthony; Alfredo Voloschin; Steven Yeh
Journal:  Int J Retina Vitreous       Date:  2022-08-26

Review 7.  Ibrutinib in primary central nervous system diffuse large B-cell lymphoma.

Authors:  Justin T Low; Katherine B Peters
Journal:  CNS Oncol       Date:  2020-03-06

8.  The value of bone marrow biopsy for staging of patients with primary CNS lymphoma.

Authors:  Michelle Margold; Sabine Seidel; Thomas Kowalski; Swetlana Ladigan-Badura; Alexander Baraniskin; Roland Schroers; Anna Verena Frey; Ingo G H Schmidt-Wolf; Ulrich Herrlinger; Agnieszka Korfel; Uwe Schlegel
Journal:  Neuro Oncol       Date:  2021-12-01       Impact factor: 12.300

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.